92 related articles for article (PubMed ID: 8770058)
1. Tenascin synthesis, deposition, and isoforms in monocrotaline-induced pulmonary hypertensive rat lungs.
Lipke DL; Aziz SM; Fagerland JA; Majesky M; Arcot SS
Am J Physiol; 1996 Aug; 271(2 Pt 1):L208-15. PubMed ID: 8770058
[TBL] [Abstract][Full Text] [Related]
2. Temporal alterations in specific basement membrane components in lungs from monocrotaline-treated rats.
Lipke DW; Arcot SS; Gillespie MN; Olson JW
Am J Respir Cell Mol Biol; 1993 Oct; 9(4):418-28. PubMed ID: 8398180
[TBL] [Abstract][Full Text] [Related]
3. Basic fibroblast growth factor alterations during development of monocrotaline-induced pulmonary hypertension in rats.
Arcot SS; Fagerland JA; Lipke DW; Gillespie MN; Olson JW
Growth Factors; 1995; 12(2):121-30. PubMed ID: 8679246
[TBL] [Abstract][Full Text] [Related]
4. Oxidative stress mediates monocrotaline-induced alterations in tenascin expression in pulmonary artery endothelial cells.
Aziz SM; Toborek M; Hennig B; Mattson MP; Guo H; Lipke DW
Int J Biochem Cell Biol; 1997 May; 29(5):775-87. PubMed ID: 9251245
[TBL] [Abstract][Full Text] [Related]
5. Lung tissue remodelling in MCT-induced pulmonary hypertension: a proposal for a novel scoring system and changes in extracellular matrix and fibrosis associated gene expression.
Franz M; Grün K; Betge S; Rohm I; Ndongson-Dongmo B; Bauer R; Schulze PC; Lichtenauer M; Petersen I; Neri D; Berndt A; Jung C
Oncotarget; 2016 Dec; 7(49):81241-81254. PubMed ID: 27835899
[TBL] [Abstract][Full Text] [Related]
6. Expression profile of matricellular proteins in hypertrophied right ventricle of monocrotaline-induced pulmonary hypertensive rats.
Imoto K; Okada M; Yamawaki H
J Vet Med Sci; 2017 Jun; 79(6):1096-1102. PubMed ID: 28496027
[TBL] [Abstract][Full Text] [Related]
7. Alterations of growth factor transcripts in rat lungs during development of monocrotaline-induced pulmonary hypertension.
Arcot SS; Lipke DW; Gillespie MN; Olson JW
Biochem Pharmacol; 1993 Sep; 46(6):1086-91. PubMed ID: 8216353
[TBL] [Abstract][Full Text] [Related]
8. Exaggerated pulmonary hypertension with monocrotaline in rats susceptible to chronic mountain sickness.
Colice GL; Hill N; Lee YJ; Du H; Klinger J; Leiter JC; Ou LC
J Appl Physiol (1985); 1997 Jul; 83(1):25-31. PubMed ID: 9216940
[TBL] [Abstract][Full Text] [Related]
9. Nonspecific endothelin-receptor antagonist blunts monocrotaline-induced pulmonary hypertension in rats.
Hill NS; Warburton RR; Pietras L; Klinger JR
J Appl Physiol (1985); 1997 Oct; 83(4):1209-15. PubMed ID: 9338430
[TBL] [Abstract][Full Text] [Related]
10. Involvement of BMPR2 in the protective effect of fluoxetine against monocrotaline-induced endothelial apoptosis in rats.
Wang Y; Zhang XH; Wang HL
Can J Physiol Pharmacol; 2011 May; 89(5):345-54. PubMed ID: 21619414
[TBL] [Abstract][Full Text] [Related]
11. Temporal alterations in basement membrane components in the pulmonary vasculature of the chronically hypoxic rat: impact of hypoxia and recovery.
Vyas-Somani AC; Aziz SM; Arcot SA; Gillespie MN; Olson JW; Lipke DW
Am J Med Sci; 1996 Aug; 312(2):54-67. PubMed ID: 8701968
[TBL] [Abstract][Full Text] [Related]
12. Dietary restriction, polyamines and monocrotaline-induced pulmonary hypertension.
Hacker AD
Biochem Pharmacol; 1993 Jun; 45(12):2475-81. PubMed ID: 8328985
[TBL] [Abstract][Full Text] [Related]
13. [Expression of GATA6 gene in lung tissue of rat with pulmonary hypertension].
Liu B; Liu HM; Yu L; Sun XJ; Wei L; Wang XM; Zhou TF
Sichuan Da Xue Xue Bao Yi Xue Ban; 2006 Nov; 37(6):864-7, 875. PubMed ID: 17236581
[TBL] [Abstract][Full Text] [Related]
14. Genistein, a phytoestrogen, attenuates monocrotaline-induced pulmonary hypertension.
Homma N; Morio Y; Takahashi H; Yamamoto A; Suzuki T; Sato K; Muramatsu M; Fukuchi Y
Respiration; 2006; 73(1):105-12. PubMed ID: 16432296
[TBL] [Abstract][Full Text] [Related]
15. Amlodipine prevents monocrotaline-induced pulmonary arterial hypertension and prolongs survival in rats independent of blood pressure lowering.
Mawatari E; Hongo M; Sakai A; Terasawa F; Takahashi M; Yazaki Y; Kinoshita O; Ikeda U
Clin Exp Pharmacol Physiol; 2007 Jul; 34(7):594-600. PubMed ID: 17581214
[TBL] [Abstract][Full Text] [Related]
16. Interleukin-1 receptor antagonist treatment reduces pulmonary hypertension generated in rats by monocrotaline.
Voelkel NF; Tuder RM; Bridges J; Arend WP
Am J Respir Cell Mol Biol; 1994 Dec; 11(6):664-75. PubMed ID: 7946395
[TBL] [Abstract][Full Text] [Related]
17. The HMG-CoA reductase inhibitor, pravastatin, prevents the development of monocrotaline-induced pulmonary hypertension in the rat through reduction of endothelial cell apoptosis and overexpression of eNOS.
Guerard P; Rakotoniaina Z; Goirand F; Rochette L; Dumas M; Lirussi F; Bardou M
Naunyn Schmiedebergs Arch Pharmacol; 2006 Sep; 373(6):401-14. PubMed ID: 16896805
[TBL] [Abstract][Full Text] [Related]
18. Pathophysiology of infantile pulmonary arterial hypertension induced by monocrotaline.
Dias-Neto M; Luísa-Neves A; Pinho S; Gonçalves N; Mendes M; Eloy C; Lopes JM; Gonçalves D; Ferreira-Pinto M; Leite-Moreira AF; Henriques-Coelho T
Pediatr Cardiol; 2015 Jun; 36(5):1000-13. PubMed ID: 25608696
[TBL] [Abstract][Full Text] [Related]
19. [TRPC6 mediates the enhancements of pulmonary arterial tone and intracellular Ca2+ concentration of pulmonary arterial smooth muscle cells in pulmonary hypertension rats].
Zhang MF; Liu XR; Yang N; Lin MJ
Sheng Li Xue Bao; 2010 Feb; 62(1):55-62. PubMed ID: 20179889
[TBL] [Abstract][Full Text] [Related]
20. Regulation of kininogen gene expression and localization in the lung after monocrotaline-induced pulmonary hypertension in rats.
Chao J; Simson JA; Chung P; Chen LM; Chao L
Proc Soc Exp Biol Med; 1993 Jun; 203(2):243-50. PubMed ID: 8502664
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
